COVID-19 Update: The Golden Time Window for Pharmacological Treatments and Low Dose Radiation Therapy

At the beginning of the COVID-19 emergence, many scientists believed that, thanks to the proofreading enzyme of SARS-CoV-2, the virus would not have many mutations. Our team introduced the concept of radiation at extremely low doses in an attempt to establish selected pressure-free treatment approac...

全面介绍

书目详细资料
Main Authors: Seyed Mohammad Javad Mortazavi, B. F. Bahaaddini Baigy Zarandi, Abdollah Jafarzadeh, S. Alireza Mortazavi, Lembit Sihver
格式: 文件
语言:English
出版: MDPI AG 2022-07-01
丛编:Radiation
主题:
在线阅读:https://www.mdpi.com/2673-592X/2/3/20
实物特征
总结:At the beginning of the COVID-19 emergence, many scientists believed that, thanks to the proofreading enzyme of SARS-CoV-2, the virus would not have many mutations. Our team introduced the concept of radiation at extremely low doses in an attempt to establish selected pressure-free treatment approaches for COVID-19. The capacity of low-dose radiation to modulate excessive inflammatory responses, optimize the immune system, prevent the occurrence of dangerous cytokine storm, regulate lymphocyte counts, and control bacterial co-infections as well as different modalities were proposed as a treatment program for patients with severe COVID-19-associated pneumonia. There is now substantial evidence which indicates that it would be unwise not to further investigate low-dose radiation therapy (LDRT) as an effective remedy against COVID-19-associated pneumonia.
ISSN:2673-592X